Concord Biotech Overview
- Status
-
Private
- Employees
-
608
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
3
Concord Biotech General Information
Description
Manufacturer of active pharmaceutical ingredients through fermentation and semi-synthetic process and finished formulations. The company offers pharmaceutical ingredients like solid orals, oral liquid and suspensions as well as diversified therapeutic segments including immunosuppressant, hematology, oncology, anti-fungal, antibacterial and anthelmintic complying with global regulatory norms.
Contact Information
Website
www.concordbiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Primary Office
- Mondeal Heights, scon Cross Road, S.G. Highway
- 16th Floor, B-Wing
- Ahmedabad, Gujarat 380015
- India
+91 079 0000 0000
Concord Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Concord Biotech Patents
Concord Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170073374-A1 | A process for isolation pf romidepsin from fermentation broth and preparation of crystals of romidepsin | Granted | 04-Mar-2014 | 000000000 | 0 |
| US-10294276-B2 | Process for isolation of romidepsin from fermentation broth and preparation of crystals of romidepsin | Active | 04-Mar-2014 | 000000000 | 0 |
| US-20160083764-A1 | An improved process for the preparation of fidaxomicin | Granted | 23-Apr-2013 | 000000000 | 0 |
| US-10119158-B2 | Process for the preparation of fidaxomicin | Active | 23-Apr-2013 | 000000000 | 0 |
| US-20070142424-A1 | Process for producing tacrolimus (fk-506) using vegetable oil as sole source of carbon | Abandoned | 29-Jul-2004 | C12P17/188 |
Concord Biotech Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Ankur Vaid | Chief Executive Officer & Director | ||
| Sudhir Vaid | Co-Owner, Chairman & Managing Director |
Concord Biotech Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 0000 | Concord Biotech | Co-Owner, Chairman & Managing Director | 000 0000 |
Concord Biotech Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Concord Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|